What are the details of autonomic nervous system (ANS) drugs, including their classifications, mechanisms of action, dosing regimens, and clinical uses?

Autonomic Nervous System (ANS) Drugs: Clinical Overview

Classification and Mechanisms

ANS drugs are broadly divided into agents that affect the sympathetic (adrenergic) and parasympathetic (cholinergic) nervous systems, either by mimicking or blocking their actions 1, 2.

Parasympathetic (Cholinergic) Agents

Anticholinergics (Muscarinic Antagonists)

• Atropine is the prototypical parasympatholytic drug that blocks muscarinic acetylcholine receptors 3
  • Mechanism: Facilitates sinoatrial conduction and increases sinus node automaticity
  • Dosing for bradycardia: 0.5-1 mg IV, repeated every 3-5 minutes to maximum 3 mg 3, 4
  • Clinical use: Symptomatic sinus bradycardia or AV block with hemodynamic compromise
  • Critical caveat: Doses <0.5 mg paradoxically cause slower heart rates; contraindicated in heart transplant patients without autonomic reinnervation (Class III: Harm) 3, 4
  • Onset: Bimodal response with acceleration at higher doses 3

Cholinergic Agonists

• Used primarily in specific autonomic disorders, though less commonly in acute settings 1, 2

Sympathetic (Adrenergic) Agents

Beta-Adrenergic Agonists

• Isoproterenol (nonselective β-agonist) 3

  • Mechanism: Chronotropic and inotropic effects without vasopressor action
  • Dosing: 20-60 mcg IV bolus followed by 10-20 mcg doses, or infusion 1-20 mcg/min
  • Use: Symptomatic bradycardia in patients at low likelihood of coronary ischemia (Class IIb)
  • Caution: Monitor for ischemic chest pain

• Dopamine 3

  • Mechanism: Mixed α-adrenergic, β-adrenergic, and dopaminergic effects (dose-dependent)
  • Dosing: Start 5 mcg/kg/min IV, increase by 5 mcg/kg/min every 2 minutes to maximum 20 mcg/kg/min
  • Dose effects: 1-2 mcg/kg/min = vasodilation; 5-20 mcg/kg/min = chronotropy/inotropy
  • Warning: Doses >20 mcg/kg/min cause vasoconstriction and arrhythmias

• Epinephrine 3

  • Mechanism: Strong α and β-adrenergic stimulation
  • Dosing: 2-10 mcg/min IV or 0.1-0.5 mcg/kg/min, titrated to effect
  • Effects: Increases chronotropy, inotropy, blood pressure, and myocardial oxygen consumption

Beta-Adrenergic Antagonists (Beta-Blockers)

Beta-blockers are Vaughan Williams Class II antiarrhythmics that inhibit sympathetic activity and slow phase IV repolarization 5.

• Cardioselective (β1-selective): Metoprolol, atenolol, bisoprolol, betaxolol 6, 7

  • Preferred in bronchospastic disease
  • Bisoprolol and metoprolol succinate preferred in heart failure with reduced ejection fraction

• Nonselective: Propranolol, nadolol 6, 7

  • Contraindicated in reactive airways disease

• Combined α/β-blockers: Carvedilol, labetalol 6, 7

  • Carvedilol preferred in HFrEF

• Cardioselective with vasodilatory properties: Nebivolol 6, 7

  • Induces nitric oxide-mediated vasodilation

• IV beta-blockers for rate control 5:

  • Esmolol: Loading 500-1000 mcg/kg/min over 1 minute, then 50 mcg/kg/min infusion (max 200 mcg/kg/min)
  • Metoprolol: Reduces ventricular response within 5 minutes
  • Critical warning: Profound bradycardia with concurrent diltiazem/verapamil; contraindicated with accessory pathways

Alpha-Adrenergic Antagonists

• Alpha-1 blockers: Doxazosin (1-16 mg/day), prazosin (2-20 mg/day), terazosin (1-20 mg/day) 6, 7

  • Use: Hypertension, benign prostatic hyperplasia
  • Major side effect: Orthostatic hypotension, especially in elderly

• Nonselective alpha antagonist: Phentolamine 8

  • Dosing: 5 mg IV bolus, repeat every 10 minutes
  • Use: Hypertensive emergencies from catecholamine excess (pheochromocytoma, cocaine, amphetamine, clonidine withdrawal)

Central Alpha-2 Agonists

• Clonidine (oral 0.1-0.8 mg/day or patch 0.1-0.3 mg weekly) 6, 7
• Methyldopa (250-1000 mg/day)
• Guanfacine (0.5-2 mg/day)
• Reserved as last-line due to significant CNS adverse effects in elderly
• Critical warning: Never abruptly discontinue clonidine—may induce hypertensive crisis; must taper

Calcium Channel Blockers (Class IV Antiarrhythmics)

Nondihydropyridines

• Diltiazem 5

  • Mechanism: Inhibits L-type calcium channels in nodal tissue
  • Use: Ventricular rate control in atrial fibrillation (70-90% effective)
  • Onset: 2-7 minutes IV
  • Warning: Profound bradycardia with concurrent beta-blockers

• Verapamil 9

  • Dosing: 5-10 mg IV over 60 seconds
  • Use: Definite SVT
  • Contraindications: Concurrent beta-blockers, Wolff-Parkinson-White syndrome (may precipitate VT/VF)

Dihydropyridines (for hypertensive emergencies) 8

• Nicardipine: Initial 5 mg/h IV, increase by 2.5 mg/h every 5 minutes to max 15 mg/h
• Clevidipine: Initial 1-2 mg/h, doubling every 90 seconds (max 32 mg/h, max duration 72 hours)
  • Contraindicated in soy/egg allergy, lipid metabolism defects

Specific Clinical Scenarios

Bradycardia Management Algorithm 3, 4, 3

1. First-line: Atropine 0.5-1 mg IV (Class IIa) if symptomatic or hemodynamically compromised
2. If inadequate response and low ischemia risk: Consider isoproterenol, dopamine, or epinephrine (Class IIb)
3. Never use atropine in heart transplant patients without reinnervation

Drug Overdose Reversal 3, 4, 3

Calcium channel blocker overdose

• Calcium chloride 10%: 1-2 g IV every 10-20 minutes or infusion 0.2-0.4 mL/kg/h
• Calcium gluconate 10%: 3-6 g IV every 10-20 minutes or infusion 0.6-1.2 mL/kg/h

Beta-blocker or calcium channel blocker overdose

• Glucagon: 3-10 mg IV with infusion 3-5 mg/h
• High-dose insulin: 1 unit/kg IV bolus, then 0.5 units/kg/h infusion (monitor glucose and potassium)

Digoxin overdose

• Digoxin antibody fragment: Dose dependent on amount ingested (one vial binds ~0.5 mg digoxin)
• Administer over ≥30 minutes, may repeat

Post-Heart Transplant Bradycardia 3, 4, 3

• Aminophylline: 6 mg/kg in 100-200 mL IV over 20-30 minutes (Class IIa)
• Theophylline: 300 mg IV, then oral 5-10 mg/kg/day titrated to effect
• Therapeutic levels 10-20 mcg/mL; post-transplant doses often lower

Hypertensive Emergency Management 8

Preferred agents based on clinical scenario:

• Acute coronary syndrome/pulmonary edema: Nitroglycerin (initial 5 mcg/min, increase by 5 mcg/min every 3-5 minutes to max 20 mcg/min)
• Aortic dissection: Esmolol + vasodilator
• Catecholamine excess: Phentolamine
• General use: Nicardipine or clevidipine (no dose adjustment needed for elderly with nicardipine)

Sodium nitroprusside 8

• Initial 0.3-0.5 mcg/kg/min, increase by 0.5 mcg/kg/min increments (max 10 mcg/kg/min)
• Critical warning: For rates ≥4-10 mcg/kg/min or duration >30 minutes, coadminister thiosulfate to prevent cyanide toxicity
• Requires intra-arterial BP monitoring

Key Clinical Pitfalls

1. Atropine paradox: Doses <0.5 mg cause bradycardia; always use ≥0.5 mg 3
2. Beta-blocker + calcium channel blocker: Profound bradycardia—avoid concurrent IV administration 9, 5
3. Verapamil in WPW: May precipitate VT/VF via accessory pathway conduction 9
4. Clonidine withdrawal: Must taper to avoid hypertensive crisis 6, 7
5. Dopamine >20 mcg/kg/min: Vasoconstriction and arrhythmias 3
6. Isoproterenol monitoring: Watch for ischemic chest pain 3
7. High-dose insulin therapy: Requires glucose and potassium monitoring 3, 4